scout
|Videos|March 29, 2021

Examining the Role of Frontline BTKi Monotherapy in CLL

Expert perspectives on the use of frontline BTKi (Bruton's tyrosine kinase inhibitors) monotherapy in the treatment of chronic lymphocytic leukemia (CLL).

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME